These findings indicate the tumor-associated release of granule-stored ARG1 in cancer patients, which is in line with the elevated ARG1 levels and activity, as well as decreased arginine levels, found in the plasma of patients with diverse tumor types (Figure 5B) (29, 111, 117, 126, 134). Here, ARG1 is linked to cancer.